Cargando…
Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a need for better tools to guide treatment selection and follow‐up. The aim of this prospective study was to investigate the prognostic value and treatment monitoring potential of longitudinal circulating tumour DNA (ctDNA) measurement...
Autores principales: | Edland, Karin Hestnes, Tjensvoll, Kjersti, Oltedal, Satu, Dalen, Ingvild, Lapin, Morten, Garresori, Herish, Glenjen, Nils, Gilje, Bjørnar, Nordgård, Oddmund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483602/ https://www.ncbi.nlm.nih.gov/pubmed/37341038 http://dx.doi.org/10.1002/1878-0261.13472 |
Ejemplares similares
-
Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
por: Nordgård, Oddmund, et al.
Publicado: (2022) -
Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
por: Lapin, Morten, et al.
Publicado: (2023) -
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
por: Lapin, Morten, et al.
Publicado: (2018) -
Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing
por: Tjensvoll, Kjersti, et al.
Publicado: (2022) -
MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
por: Lapin, Morten, et al.
Publicado: (2016)